Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization

Objective It has been proved that glucagon-like peptide-1 receptor (GLP1R) agonists have positive effects on renal outcomes in diabetic patients. However, it remains unknown whether GLP1R agonists could provide similar protection against other kidney diseases.Methods We performed two-sample Mendelia...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yu-Xuan Yao, Chen Tang, Feng-Lei Si, Ji-Cheng Lv, Su-Fang Shi, Xu-Jie Zhou, Li-Jun Liu, Hong Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
Colecção:	Renal Failure
Assuntos:	Glucagon-like peptide-1 receptor agonists chronic kidney disease diabetic nephropathy IgA nephropathy Mendelian randomization
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2478488
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!